Tag: Medtronic
-
The Widespread “Off-Label” Use Of Medtronic Infuse Bone Graft And Associated Reports Of Adverse Events Involving Serious Injury
Up To 85% Of The Times This Infuse Device / System "Hybrid" Product Is Used By Surgeons, It Is For Some Surgery Type Not Approved By The FDA (Posted by Tom Lamb at DrugInjuryWatch.com) An April 2013…
-
Infuse Bone Graft: Medtronic-Funded Studies Essentially Ignored Serious Medical Complications And Side Effects Associated With Its Back Surgery Product
A 2009 – 2012 Series Of Investigative Reports Published By The Milwaukee Journal Sentinel Exposed Various "Problems" With How Medtronic Went About Boosting Sales Of Infuse (Posted by Tom Lamb at DrugInjuryWatch.com) In the…
-
Medtronic Infuse Bone Graft Efficacy And Safety Study By Yale: Widely Anticipated Results Are Set To Be Released In June 2013
This Controversial Medtronic Spine Treatment Was Put In The Spotlight By June 2011 Medical Journal Articles About Serious Risks And Problems With Infuse (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: "Medtronic bone graft has…
-
An Increase In Complications Due To Surgical Revision Of Defective Sprint Fidelis Leads
Lead Wire Extraction Surgery Might Be More Hazardous Than Once Thought, Including Serious Cardiovascular Injuries And Deaths (Posted by Tom Lamb at DrugInjuryWatch.com)The Sprint Fidelis lead wire, a heart defibrillator cable made by Medtronic, was…
-
There Is Disagreement Over The Three-Year Failure Rate For Sprint Fidelis Lead Wires
Medtronic Says 4.6 Percent Of Leads Failed, While Reports From Some Hospitals Indicate 9.2 Percent Of Sprint Fidelis Wires Failed (Posted by Tom Lamb at DrugInjuryWatch.com) In our December 30, 2009 article, "Sprint Fidelis Lead Wire Failure…
-
Sprint Fidelis Lead Wire Failure Rate Could Rise To 30 Percent By Four Years
About 260,000 Medtronic Sprint Fidelis Leads Were Implanted In US, With Approximately 143,000 Still Active (Posted by Tom Lamb at DrugInjuryWatch.com) The December 28, 2009 edition of "US Morning Meeting Highlights" from UBS Investment…